LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease.
复制标题
DOI:
10.1016/j.nbd.2010.04.002
复制
发表时间:
2010-10
影响因子:
6.1
通讯作者:
Chen SG
中科院分区:
文献类型:
--
作者:
Yao C;El Khoury R;Wang W;Byrd TA;Pehek EA;Thacker C;Zhu X;Smith MA;Wilson-Delfosse AL;Chen SG
Mutations in LRRK2 are thus far the most frequent known cause of autosomal dominant and idiopathic Parkinson’s disease (PD) with prevalent mutations being found within the GTPase (R1441C/G) and kinase (G2019S) domains. Previous in vitro studies have revealed that R1441C and G2019S mutations are associated with increased kinase activity. To better understand LRRK2-linked PD pathogenesis in vivo, we have generated transgenic C. elegans overexpressing human LRRK2 wild type, R1441C and G2019S in dopaminergic (DA) neurons. Overexpression of these LRRK2 proteins causes age-dependent DA neurodegeneration, behavioral deficits, and locomotor dysfunction that are accompanied by a reduction of dopamine levels in vivo. In comparison, R1441C and G2019S mutants cause more severe phenotypes than the wild type protein. Interestingly, treatment with exogenous dopamine rescues the LRRK2-induced behavioral and locomotor phenotypes. In contrast, expression of the GTP binding defective mutant, K1347A, or knockout of the C. elegans LRRK2 homolog, LRK-1, prevents the LRRK2-induced neurodegeneration and behavioral abnormalities. Hence, our transgenic LRRK2 C. elegans models recapitulate key features of PD including progressive neurodegeneration, impairment of dopamine-dependent behavior and locomotor function, and reduction in dopamine levels. Furthermore, our findings provide strong support for the critical role of GTPase/kinase activity in LRRK2-linked pathologies. These invertebrate models will be useful for studying pathogenesis of PD and for development of potential therapeutics for the disease.
登录
查看更多内容
影响因子:
3
作者:
Feng Z;Cronin CJ;Wittig JH Jr;Sternberg PW;Schafer WR
通讯作者:
Schafer WR
影响因子:
4.2
作者:
Gandhi, Payal N.;Chen, Shu G.;Wilson-Delfosse, Amy L.
通讯作者:
Wilson-Delfosse, Amy L.
影响因子:
25
作者:
Li, Yanping;Liu, Wencheng;Oo, Tinmarla F.;Wang, Lei;Tang, Yi;Jackson-Lewis, Vernice;Zhou, Chun;Geghman, Kindiya;Bogdanov, Mikhail;Przedborski, Serge;Beal, M. Flint;Burke, Robert E.;Li, Chenjian
通讯作者:
Li, Chenjian
影响因子:
4.8
作者:
Saermann, Julia;Hegermann, Jan;Schmidt, Enrico
通讯作者:
Schmidt, Enrico
影响因子:
4.7
作者:
Artal-Sanz, Marto;de Jong, Liesbeth;Tavernarakis, Nektarios
通讯作者:
Tavernarakis, Nektarios